| T38 | Name: | 2'-O-ETHOXYMETHYLENE THYMIDINE 5'-MONOPHOSPHATE | Formula: | C13 H21 N2 O10 P | SMILES: | P(=O)(O)(O)OCC1OC(C(C1O)OCOCC)N2C(=O)NC(=O)C(C)=C2 | InChi: | InChI=1S/C13H21N2O10P/c1-3-22-6-23-10-9(16)8(5-24-26(19,20)21)25-12(10)15-4-7(2)11(17)14-13(15)18/h4,8-10,12,16H,3,5-6H2,1-2H3,(H,14,17,18)(H2,19,20,21)/t8-,9-,10-,12-/m1/s1 | Definition date: | 1998-07-29 | Last modified: | 2018-03-14 | Identifier: | 2'-O-(ethoxymethyl)-5-methyluridine 5'-(dihydrogen phosphate) |
|
| T41 | Name: | 1-(2-O-METHYL-BETA-D-ARABINOFURANOSYL)THYMIDINE 5'-MONOPHOSPHATE | Formula: | C11 H17 N2 O9 P | SMILES: | N1(C(NC(C(C)=C1)=O)=O)C2C(OC)C(C(O2)COP(=O)(O)O)O | InChi: | InChI=1S/C11H17N2O9P/c1-5-3-13(11(16)12-9(5)15)10-8(20-2)7(14)6(22-10)4-21-23(17,18)19/h3,6-8,10,14H,4H2,1-2H3,(H,12,15,16)(H2,17,18,19)/t6-,7-,8+,10-/m1/s1 | Definition date: | 1995-10-15 | Last modified: | 2018-03-14 | Identifier: | 5-methyl-1-(2-O-methyl-5-O-phosphono-beta-D-arabinofuranosyl)pyrimidine-2,4(1H,3H)-dione |
|
| 8TE | Name: | p-Methylphosphonatocalix[4]arene | Formula: | C32 H36 O16 P4 | SMILES: | Oc1c2Cc3cc(C[P](O)(O)=O)cc(Cc4cc(C[P](O)(O)=O)cc(Cc5cc(C[P](O)(O)=O)cc(Cc1cc(C[P](O)(O)=O)c2)c5O)c4O)c3O | InChi: | InChI=1S/C32H36O16P4/c33-29-21-1-17(13-49(37,38)39)2-22(29)10-24-5-19(15-51(43,44)45)6-27(31(24)35)12-28-8-20(16-52(46,47)48)7-26(32(28)36)11-25-4-18(14-50(40,41)42)3-23(9-21)30(25)34/h1-8,33-36H,9-16H2,(H2,37,38,39)(H2,40,41,42)(H2,43,44,45)(H2,46,47,48) | Definition date: | 2017-03-07 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 |
|
| 8VM | Name: | 5-(3-{4-[(2S)-2-hydroxy-3,3-dimethylbutoxy]-3-methylphenyl}pentan-3-yl)-3-methyl-N-(1H-tetrazol-5-yl)thiophene-2-carboxamide | Formula: | C25 H35 N5 O3 S | SMILES: | C(c2c(cc(C(c1ccc(c(c1)C)OCC(C(C)(C)C)O)(CC)CC)s2)C)(Nc3nnnn3)=O | InChi: | InChI=1S/C25H35N5O3S/c1-8-25(9-2,17-10-11-18(15(3)12-17)33-14-19(31)24(5,6)7)20-13-16(4)21(34-20)22(32)26-23-27-29-30-28-23/h10-13,19,31H,8-9,14H2,1-7H3,(H2,26,27,28,29,30,32)/t19-/m1/s1 | Definition date: | 2017-03-07 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 5-(3-{4-[(2S)-2-hydroxy-3,3-dimethylbutoxy]-3-methylphenyl}pentan-3-yl)-3-methyl-N-(1H-tetrazol-5-yl)thiophene-2-carboxamide |
|
| EXD | Name: | 2-(trifluoromethyl)-1H-benzimidazol-7-ol | Formula: | C8 H5 F3 N2 O | SMILES: | c1c(c2nc(C(F)(F)F)nc2cc1)O | InChi: | InChI=1S/C8H5F3N2O/c9-8(10,11)7-12-4-2-1-3-5(14)6(4)13-7/h1-3,14H,(H,12,13) | Definition date: | 2018-02-08 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 2-(trifluoromethyl)-1H-benzimidazol-7-ol |
|
| EXG | Name: | 1-benzyl-1H-imidazo[4,5-b]pyridine | Formula: | C13 H11 N3 | SMILES: | c1(ccccc1)Cn3c2cccnc2nc3 | InChi: | InChI=1S/C13H11N3/c1-2-5-11(6-3-1)9-16-10-15-13-12(16)7-4-8-14-13/h1-8,10H,9H2 | Definition date: | 2018-02-08 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 1-benzyl-1H-imidazo[4,5-b]pyridine |
|
| EXJ | Name: | (3R)-3-(3-chlorophenyl)-3-[(5-methyl-7-oxo-6,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)amino]propanenitrile | Formula: | C15 H13 Cl N6 O | SMILES: | C1(C)=Nc3n(C(C1)=O)nc(NC(CC#N)c2cc(Cl)ccc2)n3 | InChi: | InChI=1S/C15H13ClN6O/c1-9-7-13(23)22-15(18-9)20-14(21-22)19-12(5-6-17)10-3-2-4-11(16)8-10/h2-4,8,12H,5,7H2,1H3,(H,19,21)/t12-/m1/s1 | Definition date: | 2018-02-08 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | (3R)-3-(3-chlorophenyl)-3-[(5-methyl-7-oxo-6,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)amino]propanenitrile |
|
| EXP | Name: | 2-{[(3-bromophenyl)methyl]amino}-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7(6H)-one | Formula: | C13 H12 Br N5 O | SMILES: | c12nc(nn1C(CC(C)=N2)=O)NCc3cc(ccc3)Br | InChi: | InChI=1S/C13H12BrN5O/c1-8-5-11(20)19-13(16-8)17-12(18-19)15-7-9-3-2-4-10(14)6-9/h2-4,6H,5,7H2,1H3,(H,15,18) | Definition date: | 2018-02-08 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 2-{[(3-bromophenyl)methyl]amino}-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7(6H)-one |
|
| EXS | Name: | (2R)-2,4-dihydroxy-N-[2-(7-hydroxy-1H-benzimidazol-2-yl)ethyl]-3,3-dimethylbutanamide | Formula: | C15 H21 N3 O4 | SMILES: | c2(nc1c(cccc1O)n2)CCNC(=O)C(C(C)(C)CO)O | InChi: | InChI=1S/C15H21N3O4/c1-15(2,8-19)13(21)14(22)16-7-6-11-17-9-4-3-5-10(20)12(9)18-11/h3-5,13,19-21H,6-8H2,1-2H3,(H,16,22)(H,17,18)/t13-/m0/s1 | Definition date: | 2018-02-08 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | (2R)-2,4-dihydroxy-N-[2-(7-hydroxy-1H-benzimidazol-2-yl)ethyl]-3,3-dimethylbutanamide |
|
| EXV | Name: | 3-[(1S,2S)-2-(7-hydroxy-1H-benzimidazol-2-yl)cyclopentyl]benzoic acid | Formula: | C19 H18 N2 O3 | SMILES: | c1(cccc(c1)C2C(CCC2)c3nc4c(n3)cccc4O)C(=O)O | InChi: | InChI=1S/C19H18N2O3/c22-16-9-3-8-15-17(16)21-18(20-15)14-7-2-6-13(14)11-4-1-5-12(10-11)19(23)24/h1,3-5,8-10,13-14,22H,2,6-7H2,(H,20,21)(H,23,24)/t13-,14+/m1/s1 | Definition date: | 2018-02-08 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 3-[(1S,2S)-2-(7-hydroxy-1H-benzimidazol-2-yl)cyclopentyl]benzoic acid |
|
| JTY | Name: | 5-(phenylsulfonylamino)-1,3-thiazole-4-carboxylic acid | Formula: | C10 H8 N2 O4 S2 | SMILES: | OC(=O)c1ncsc1N[S](=O)(=O)c2ccccc2 | InChi: | InChI=1S/C10H8N2O4S2/c13-10(14)8-9(17-6-11-8)12-18(15,16)7-4-2-1-3-5-7/h1-6,12H,(H,13,14) | Definition date: | 2017-01-24 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 5-(phenylsulfonylamino)-1,3-thiazole-4-carboxylic acid |
|
| 9FG | Name: | 5-(2-fluoro-4-hydroxyphenyl)-1-methyl-1H-pyrrole-2-carbonitrile | Formula: | C12 H9 F N2 O | SMILES: | C(c1n(c(cc1)c2c(F)cc(cc2)O)C)#N | InChi: | InChI=1S/C12H9FN2O/c1-15-8(7-14)2-5-12(15)10-4-3-9(16)6-11(10)13/h2-6,16H,1H3 | Definition date: | 2017-05-04 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 5-(2-fluoro-4-hydroxyphenyl)-1-methyl-1H-pyrrole-2-carbonitrile |
|
| 8Z4 | Name: | (4AS,8AR)-4-(3-{4-[(3R)-3-HYDROXYPYRROLIDINE-1- | Formula: | C29 H33 N3 O4 | SMILES: | COc1ccc(cc1c2ccc(cc2)C(=O)N3CC[CH](O)C3)C4=NN(C(C)C)C(=O)[CH]5CC=CC[CH]45 | InChi: | InChI=1S/C29H33N3O4/c1-18(2)32-29(35)24-7-5-4-6-23(24)27(30-32)21-12-13-26(36-3)25(16-21)19-8-10-20(11-9-19)28(34)31-15-14-22(33)17-31/h4-5,8-13,16,18,22-24,33H,6-7,14-15,17H2,1-3H3/t22-,23+,24-/m1/s1 | Definition date: | 2016-06-06 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | (4aS,8aR)-4-[4-methoxy-3-[4-[(3R)-3-oxidanylpyrrolidin-1-yl]carbonylphenyl]phenyl]-2-propan-2-yl-4a,5,8,8a-tetrahydrophthalazin-1-one |
|
| 8ZV | Name: | 2-{[3,5-bis(2-methoxyethoxy)benzene-1-carbonyl]amino}ethyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate | Formula: | C28 H38 N2 O9 S | SMILES: | C(CNC(c1cc(cc(OCCOC)c1)OCCOC)=O)OC(C2CCCCN2S(Cc3ccccc3)(=O)=O)=O | InChi: | InChI=1S/C28H38N2O9S/c1-35-14-16-37-24-18-23(19-25(20-24)38-17-15-36-2)27(31)29-11-13-39-28(32)26-10-6-7-12-30(26)40(33,34)21-22-8-4-3-5-9-22/h3-5,8-9,18-20,26H,6-7,10-17,21H2,1-2H3,(H,29,31)/t26-/m0/s1 | Definition date: | 2017-03-23 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 2-{[3,5-bis(2-methoxyethoxy)benzene-1-carbonyl]amino}ethyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate |
|
| 908 | Name: | 4-[5-[(4~{a}~{R},8~{a}~{S})-4-oxidanylidene-3-propan-2-yl-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-yl]-2-methoxy-phenyl]-~{N}-(2-azanyl-2-oxidanylidene-ethyl)benzamide | Formula: | C27 H30 N4 O4 | SMILES: | COc1ccc(cc1c2ccc(cc2)C(=O)NCC(N)=O)C3=NN(C(C)C)C(=O)[CH]4CC=CC[CH]34 | InChi: | InChI=1S/C27H30N4O4/c1-16(2)31-27(34)21-7-5-4-6-20(21)25(30-31)19-12-13-23(35-3)22(14-19)17-8-10-18(11-9-17)26(33)29-15-24(28)32/h4-5,8-14,16,20-21H,6-7,15H2,1-3H3,(H2,28,32)(H,29,33)/t20-,21+/m0/s1 | Definition date: | 2016-06-08 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 4-[5-[(4~{a}~{R},8~{a}~{S})-4-oxidanylidene-3-propan-2-yl-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-yl]-2-methoxy-phenyl]-~{N}-(2-azanyl-2-oxidanylidene-ethyl)benzamide |
|
| 92H | Name: | ~{N}-[[(3~{R})-1-(2,3-dihydro-1~{H}-inden-2-yl)piperidin-3-yl]methyl]-~{N}-[2-(dimethylamino)ethyl]naphthalene-2-carboxamide | Formula: | C30 H37 N3 O | SMILES: | CN(C)CCN(C[CH]1CCCN(C1)C2Cc3ccccc3C2)C(=O)c4ccc5ccccc5c4 | InChi: | InChI=1S/C30H37N3O/c1-31(2)16-17-33(30(34)28-14-13-24-9-3-4-10-25(24)18-28)22-23-8-7-15-32(21-23)29-19-26-11-5-6-12-27(26)20-29/h3-6,9-14,18,23,29H,7-8,15-17,19-22H2,1-2H3/t23-/m1/s1 | Definition date: | 2017-04-07 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | ~{N}-[[(3~{R})-1-(2,3-dihydro-1~{H}-inden-2-yl)piperidin-3-yl]methyl]-~{N}-[2-(dimethylamino)ethyl]naphthalene-2-carboxamide |
|
| 9A8 | Name: | 2-(4-propan-2-yloxyphenyl)-3~{H}-quinazolin-4-one | Formula: | C17 H16 N2 O2 | SMILES: | CC(C)Oc1ccc(cc1)C2=Nc3ccccc3C(=O)N2 | InChi: | InChI=1S/C17H16N2O2/c1-11(2)21-13-9-7-12(8-10-13)16-18-15-6-4-3-5-14(15)17(20)19-16/h3-11H,1-2H3,(H,18,19,20) | Definition date: | 2017-05-02 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 2-(4-propan-2-yloxyphenyl)-3~{H}-quinazolin-4-one |
|
| 9AN | Name: | 2-(3-hydroxyphenyl)-3~{H}-quinazolin-4-one | Formula: | C14 H10 N2 O2 | SMILES: | Oc1cccc(c1)C2=Nc3ccccc3C(=O)N2 | InChi: | InChI=1S/C14H10N2O2/c17-10-5-3-4-9(8-10)13-15-12-7-2-1-6-11(12)14(18)16-13/h1-8,17H,(H,15,16,18) | Definition date: | 2017-05-04 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 2-(3-hydroxyphenyl)-3~{H}-quinazolin-4-one |
|
| 9AW | Name: | 2-(4-pyridin-2-ylphenyl)-3~{H}-quinazolin-4-one | Formula: | C19 H13 N3 O | SMILES: | O=C1NC(=Nc2ccccc12)c3ccc(cc3)c4ccccn4 | InChi: | InChI=1S/C19H13N3O/c23-19-15-5-1-2-7-17(15)21-18(22-19)14-10-8-13(9-11-14)16-6-3-4-12-20-16/h1-12H,(H,21,22,23) | Definition date: | 2017-05-04 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 2-(4-pyridin-2-ylphenyl)-3~{H}-quinazolin-4-one |
|
| 9AX | Name: | (2E)-3-methyl-5-[(1R,2S,8aS)-1,2,5,5-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]pent-2-en-1-yl trihydrogen diphosphate | Formula: | C20 H36 O7 P2 | SMILES: | O=P(O)(OP(=O)(O)O)OC[C@H]=C(CCC2(C)C(CC=C1C(C)(C)CCCC12)C)C | InChi: | InChI=1S/C20H36O7P2/c1-15(11-14-26-29(24,25)27-28(21,22)23)10-13-20(5)16(2)8-9-17-18(20)7-6-12-19(17,3)4/h9,11,16,18H,6-8,10,12-14H2,1-5H3,(H,24,25)(H2,21,22,23)/b15-11+/t16-,18+,20+/m0/s1 | Definition date: | 2018-02-26 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | (2E)-3-methyl-5-[(1R,2S,8aS)-1,2,5,5-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]pent-2-en-1-yl trihydrogen diphosphate |
|
| 9B2 | Name: | 2-(4-piperidin-1-ylphenyl)-3~{H}-quinazolin-4-one | Formula: | C19 H19 N3 O | SMILES: | O=C1NC(=Nc2ccccc12)c3ccc(cc3)N4CCCCC4 | InChi: | InChI=1S/C19H19N3O/c23-19-16-6-2-3-7-17(16)20-18(21-19)14-8-10-15(11-9-14)22-12-4-1-5-13-22/h2-3,6-11H,1,4-5,12-13H2,(H,20,21,23) | Definition date: | 2017-05-04 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 2-(4-piperidin-1-ylphenyl)-3~{H}-quinazolin-4-one |
|
| 6VK | Name: | (4~{S})-3-cyclopropyl-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Formula: | C22 H25 N3 O | SMILES: | CC1(C)CC(=O)C2=C(C1)Nc3n[nH]c(C4CC4)c3[C]2(C)c5ccccc5 | InChi: | InChI=1S/C22H25N3O/c1-21(2)11-15-17(16(26)12-21)22(3,14-7-5-4-6-8-14)18-19(13-9-10-13)24-25-20(18)23-15/h4-8,13H,9-12H2,1-3H3,(H2,23,24,25)/t22-/m1/s1 | Definition date: | 2016-07-05 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | (4~{S})-3-cyclopropyl-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one |
|
| 6VL | Name: | (4~{S})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Formula: | C20 H23 N3 O | SMILES: | CC[C]1(c2ccccc2)c3c[nH]nc3NC4=C1C(=O)CC(C)(C)C4 | InChi: | InChI=1S/C20H23N3O/c1-4-20(13-8-6-5-7-9-13)14-12-21-23-18(14)22-15-10-19(2,3)11-16(24)17(15)20/h5-9,12H,4,10-11H2,1-3H3,(H2,21,22,23)/t20-/m0/s1 | Definition date: | 2016-07-05 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | (4~{S})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one |
|
| 6VM | Name: | (4~{S})-3-(2,2-dimethylpropyl)-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Formula: | C24 H31 N3 O | SMILES: | CC(C)(C)Cc1[nH]nc2NC3=C(C(=O)CC(C)(C)C3)[C](C)(c4ccccc4)c12 | InChi: | InChI=1S/C24H31N3O/c1-22(2,3)12-17-20-21(27-26-17)25-16-13-23(4,5)14-18(28)19(16)24(20,6)15-10-8-7-9-11-15/h7-11H,12-14H2,1-6H3,(H2,25,26,27)/t24-/m1/s1 | Definition date: | 2016-07-05 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | (4~{S})-3-(2,2-dimethylpropyl)-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one |
|
| CVA | Name: | 2-[(4-{5-[(4aR,8aS)-3-cycloheptyl-4-oxo-3,4,4a,5,8,8a-hexahydrophthalazin-1-yl]-2-methoxyphenyl}phenyl)formamido]-N-(2-hydroxyethyl)acetamide | Formula: | C33 H40 N4 O5 | SMILES: | COc1ccc(cc1c2ccc(cc2)C(=O)NCC(=O)NCCO)C3=NN(C4CCCCCC4)C(=O)[CH]5CC=CC[CH]35 | InChi: | InChI=1S/C33H40N4O5/c1-42-29-17-16-24(20-28(29)22-12-14-23(15-13-22)32(40)35-21-30(39)34-18-19-38)31-26-10-6-7-11-27(26)33(41)37(36-31)25-8-4-2-3-5-9-25/h6-7,12-17,20,25-27,38H,2-5,8-11,18-19,21H2,1H3,(H,34,39)(H,35,40)/t26-,27+/m0/s1 | Definition date: | 2016-06-09 | Last modified: | 2018-03-09 | Release date: | 2018-03-14 | Identifier: | 4-[5-[(4~{a}~{R},8~{a}~{S})-3-cycloheptyl-4-oxidanylidene-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-yl]-2-methoxy-phenyl]-~{N}-[2-(2-hydroxyethylamino)-2-oxidanylidene-ethyl]benzamide |
|